High Pass-Rate OG0-093 Questions Exam, Valid Exam OG0-093 Braindumps

What's more, part of that Prep4cram OG0-093 dumps now are free: https://drive.google.com/open?id=1PFP4q6XrRL7ZLKSxwP9mqKAmjF0VDrXu

You are lucky to be here with our OG0-093 training materials for we are the exact vendor who devote ourselves to produce the best OG0-093 exam questions and helping our customers successfully get their dreaming certification of OG0-093 Real Exam. We own the first-class team of professional experts and customers’ servers concentrating on the improvement of our OG0-093 study guide. So your success is guaranteed.

The Open Group OG0-093 Exam Syllabus Topics:

Section	Weight	Objectives
Architecture Development Method (ADM)	25%	- ADM cycle, phases and purpose 1. Preliminary Phase 2. Phase C: Information Systems Architectures 3. Phase E: Opportunities and Solutions 4. Phase D: Technology Architecture 5. Phase F: Migration Planning 6. Phase G: Implementation Governance 7. Phase H: Architecture Change Management 8. Phase B: Business Architecture 9. Phase A: Architecture Vision - Adapting and applying ADM in different contexts - Requirements Management
ADM Guidelines and Techniques	15%	- Gap analysis, interoperability and migration planning - Architecture principles, deliverables and artifacts - Security, risk and governance considerations - Stakeholder management, views and viewpoints
Basic Concepts and Terminology	15%	- Architecture domains: business, data, application, technology - Enterprise architecture fundamentals - TOGAF definitions and core terminology - Principles and benefits of enterprise architecture
Core TOGAF Concepts	20%	- Architecture Content Framework and Metamodel - Architecture Building Blocks and Solution Building Blocks - TOGAF structure and components - Enterprise Continuum and Architecture Repository - Architecture Capability Framework
TOGAF Reference Models	10%	- Integrated Information Infrastructure Reference Model (III-RM) - Technical Reference Model (TRM)
Architecture Governance	15%	- Compliance, maturity models and assessment - Governance frameworks and processes - Architecture Board and decision-making

>> OG0-093 Questions Exam <<

Valid Exam OG0-093 Braindumps, OG0-093 Examcollection Dumps

The countless candidates have already passed their OG0-093 certification exam and they all used the real, valid, and updated Prep4cram OG0-093 exam questions. So, why not, take a decision right now and ace your OG0-093 Exam Preparation with top-notch OG0-093 exam questions?

The Open Group TOGAF 9 Combined Part 1 and Part 2 Sample Questions (Q212-Q217):

NEW QUESTION # 212
Complete the sentence. TOGAF defines five criteria for a good set of principles: Understandable, Robust, Complete, Consistent and_____.

A. Stable
B. Agile
C. Comprehensive
D. Rational
E. Dynamic

Answer: A

NEW QUESTION # 213
Consider the following ADM phases objectives.

Which phase does each objective match?

A. 1G-2H-3H-4F
B. 1H-2F-3F-4G
C. 1F-2G-3H-4H
D. 1F-2G-3G-4H

Answer: B

NEW QUESTION # 214
Which of the following best describes the purpose of the Architecture Definition Document?

A. To ensure that architecture information is communicated to the right stakeholders at the right time
B. To act as a deliverable container for artifacts created during a project
C. To show progression of change from the Baseline Architecture to the Target Architecture
D. To provide a high-level view of the end architecture product
E. To govern the architecture throughout its implementation process

Answer: B

Explanation:
Section: Part 2
Explanation
Explanation/Reference:
Reference https://pubs.opengroup.org/architecture/togaf91-doc/arch/chap36.html

NEW QUESTION # 215
According to TOGAF, where should architecture governance artifacts be stored?

A. In the Architecture Repository
B. In the Foundation Architecture
C. In the Standards Information Base
D. In the Integrated Information Infrastructure Reference Model

Answer: A

Explanation:
Section: Part 2

NEW QUESTION # 216
Scenario
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for an enterprise architecture project team within a leading multinational pharmaceutical and medical devices manufacturer. Its brands include numerous household names for medications and first aid supplies.
The company has a long history of innovating new treatments for many common illnesses and diseases. Prior to launching a new treatment, the company has to demonstrate Its effectiveness and safety in a set of clinical trials that satisfy the regulatory requirements of the countries in the target markets. All clinical trials are undertaken by its research laboratories, which employ over 10,000 people at separate facilities in the United Kingdom, United States, Sweden, France, Canada, India, China and Japan. In addition to internal research and development activities the company is also involved in publicly funded collaborative research projects, with other industrial and academic partners.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners.
The Enterprise Architecture group is a mature organization. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets.
Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant.
The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the enterprise architecture for the new system will need to be rolled out in stages on a regional basis that minimizes disruptions to ongoing clinical trials.
Refer to the Scenario
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on TOGAF, which of the following is the best answer?

A. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures.
B. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using a state evolution table.
C. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
D. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product.
Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.

Answer: D

Explanation:
Section: Part 2

NEW QUESTION # 217
......

The The Open Group OG0-093 dumps PDF format of Prep4cram is portable and printable. It means you can print The Open Group OG0-093 real questions for off-screen preparation. You can also access The Open Group OG0-093 dumps PDF from smartphones, laptops, and tablets anywhere anytime to prepare for the OG0-093 Exam. This version of our OG0-093 questions PDF is beneficial for busy applicants because they can easily use OG0-093 dumps PDF and prepare for the The Open Group OG0-093 test in their homes, offices, libraries, and even while traveling.

Valid Exam OG0-093 Braindumps: https://www.prep4cram.com/OG0-093_exam-questions.html

BONUS!!! Download part of Prep4cram OG0-093 dumps for free: https://drive.google.com/open?id=1PFP4q6XrRL7ZLKSxwP9mqKAmjF0VDrXu